Skip to main content
. 2015 Apr 7;10(4):e0123014. doi: 10.1371/journal.pone.0123014

Table 4. Neurological sequelae of infants with invasive Group B Streptococcus (GBS) disease at 3 and 6 month visits.

Cases Controls Univariate-OR (95%CI) 1 p-value Multivariate-OR (95%CI) 2 p-value
Sepsis Meningitis Overall
3 months n = 49 n = 19 n = 68 n = 262
Overall 3 3 (6.1) 6 (31.6) 9 (13.2) 1 (0.4) 39.81 (5.27–1751.09) <0.001 21.48 (2.58–179.15) 0.005
Abnormal Denver-II assessment 4 2 (4.1) 1 (5.3) 3 (4.4) 1 (0.4)
Hypertonia/hyper-reflexia 5 1 (2.0) 5 (26.3) 6 (8.9) 0
6 months n = 51 n = 17 n = 68 n = 232
Overall 5 (9.8) 4 (23.5) 9 (13.2) 1 (0.4) 35.24 (4.66–1550.57) <0.001 13.18 (1.44–120.95) 0.023
Abnormal Denver-II assessment 4 (7.8) 1 (5.9) 5 (7.4) 1 (0.4)
Hypertonia/hyper-reflexia 1 (2.0) 3 (17.6) 4 (5.9) 0

1 Univariate-OR(95%CI)- calculated Odds ratio with 95% confidence using Fischer exact test comparing overall cases and controls

2 Multivariate-OR(95%CI)- calculated Odds ratio with 95% confidence using conditional logistic regression (adjusted for gender. gestational age, birth weight ≥2500, perinatal asphyxia, ventilation at presentation, HIV-status and previous non-GBS admissions).

3Number (%) of cases and controls with neurological sequelae based on abnormal Denver-II assessments and hypertonia/hyper-reflexia.

4Abnormal Denver-II assessments in four tested domains (Gross Motor, Fine Motor, Language and Personal/Social).

5Hypertonia and/or hyper-reflexia on neurological examination of infant with a normal Denver-II assessment.